Farallon Capital Management’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-500,000
Closed -$1.08M 322
2022
Q2
$1.08M Buy
+500,000
New +$1.7M 0.01% 215
2022
Q1
Sell
-600,000
Closed -$3.7M 336
2021
Q4
$3.7M Buy
+600,000
New +$6.85M 0.02% 196

Other funds holding LIAN

Farallon Capital Management's LIAN Position: Q3 2022 in Review

Farallon Capital Management sold out of LianBio American Depositary Shares (LIAN) in Q3 2022, closing a stake of 500,000 shares — an estimated $1.08M sold.

Farallon Capital Management first reported a position in LIAN in Q4 2021 and held it in 2 quarters. The position peaked at $3.7M in Q4 2021. 44 funds tracked by Wall St. Rank hold LIAN as of Q3 2022.

  • Farallon Capital Management reported no remaining LianBio American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Farallon Capital Management sold 500,000 LianBio American Depositary Shares shares in Q3 2022, an estimated $1.08M.
  • Farallon Capital Management first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • Farallon Capital Management's LianBio American Depositary Shares position peaked at $3.7M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2022.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.